Pfizer concocts a ‘deal from hell’ By: MarketWatch May 15, 2014 at 06:15 AM EDT Buying AstraZeneca would be bad for everyone except the CEO, writes Howard Gold. Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Pfizer